We are live on
!
Find out more
CC
Callan Capital Portfolio holdings
AUM
$1.35B
Turnover
17.35%
1-Year Est. Return
8.35%
This Fund
S&P 500
This Quarter
Est. Return
+4.78%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$477M
AUM Growth
+$6.42M
(+1.4%)
Cap. Flow
-$17.8M
Cap. Flow
% of AUM
-3.74%
Top 10 Holdings %
Top 10 Hldgs %
75.49%
Holding
73
New
5
Increased
26
Reduced
20
Closed
3
Avg Time Held
1.3
years
Top 10 Avg Time Held
1.5
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$1.39M |
| 2 |
Invesco FTSE RAFI US 1000 ETF
PRF
|
+$1.35M |
| 3 |
State Street SPDR S&P Dividend ETF
SDY
|
+$1.21M |
| 4 |
First Trust Global Tactical Commodity Strategy Fund
FTGC
|
+$968K |
| 5 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$815K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Europe ETF
VGK
|
+$5.04M |
| 2 |
iShares MSCI Japan ETF
EWJ
|
+$1.71M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$1.58M |
| 4 |
iShares MSCI Pacific ex Japan ETF
EPP
|
+$1.36M |
| 5 |
Halozyme
HALO
|
+$920K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 97.04% |
| 2 | Healthcare | 2.02% |
| 3 | Real Estate | 0.38% |
| 4 | Consumer Staples | 0.23% |
| 5 | Materials | 0.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
RCPT
1
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $160M | 33.55% |
841,101
-4,928
| -0.6% | -$814K |
2013 Q4
6 quarters
|
|
|
2
Invesco FTSE RAFI US 1000 ETF
PRF
$10.1B
| $47.4M | 9.95% |
2,614,560
+72,785
| +3% | +$1.35M |
2013 Q2
8 quarters
|
|
|
3
State Street SPDR S&P Dividend ETF
SDY
$21.4B
| $47M | 9.86% |
616,724
+15,405
| +3% | +$1.21M |
2013 Q2
8 quarters
|
|
|
4
Vanguard FTSE Europe ETF
VGK
$29.7B
| $28.4M | 5.96% |
526,309
-89,188
| -14% | -$5.04M |
2013 Q2
8 quarters
|
|
5
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.26B
| $19.4M | 4.07% |
677,368
+14,735
| +2% | +$449K |
2014 Q2
4 quarters
|
|
|
6
First Trust Global Tactical Commodity Strategy Fund
FTGC
$3.39B
| $18.7M | 3.92% |
754,305
+39,199
| +5% | +$968K |
2014 Q4
2 quarters
|
|
|
7
Vanguard FTSE Emerging Markets ETF
VWO
$124B
| $11.1M | 2.33% |
271,305
-36,701
| -12% | -$1.58M |
2013 Q2
8 quarters
|
|
8
State Street Technology Select Sector SPDR ETF
XLK
$125B
| $10.5M | 2.19% |
504,890
+14,172
| +3% | +$302K |
2013 Q2
8 quarters
|
|
|
9
iShares MSCI Japan ETF
EWJ
$23.2B
| $8.89M | 1.87% |
173,456
-32,913
| -16% | -$1.71M |
2013 Q2
8 quarters
|
|
10
Vanguard Short-Term Corporate Bond ETF
VCSH
$44B
| $8.5M | 1.78% |
106,867
+2,574
| +2% | +$206K |
2014 Q4
2 quarters
|
|
11
State Street Health Care Select Sector SPDR ETF
XLV
$45.9B
| $7.06M | 1.48% |
94,935
+2,193
| +2% | +$163K |
2013 Q2
8 quarters
|
|
12
iShares Europe ETF
IEV
$1.6B
| $6.64M | 1.39% |
151,750
-8,393
| -5% | -$386K |
2013 Q2
8 quarters
|
|
13
State Street Financial Select Sector SPDR ETF
XLF
$51.4B
| $6.15M | 1.29% |
287,293
+8,179
| +3% | +$177K |
2013 Q2
8 quarters
|
|
14
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.2B
| $6.13M | 1.29% |
160,440
+3,030
| +2% | +$116K |
2013 Q2
8 quarters
|
|
|
15
iShares MSCI Pacific ex Japan ETF
EPP
$2.21B
| $6.05M | 1.27% |
139,413
-29,327
| -17% | -$1.36M |
2013 Q2
8 quarters
|
|
16
Vanguard FTSE All-World ex-US ETF
VEU
$67.4B
| $5.58M | 1.17% |
114,955
-9,386
| -8% | -$476K |
2013 Q2
8 quarters
|
|
17
Vanguard Morningstar Mid-Cap ETF
VO
$107B
| $5.1M | 1.07% |
160,180
+3,532
| +2% | +$115K |
2013 Q2
8 quarters
|
|
18
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.65B
| $5.06M | 1.06% |
243,855
+1,410
| +0.6% | +$29.6K |
2013 Q2
8 quarters
|
|
19
State Street Industrial Select Sector SPDR ETF
XLI
$30.6B
| $4.72M | 0.99% |
87,394
+2,011
| +2% | +$113K |
2013 Q2
8 quarters
|
|
20
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.5B
| $4.7M | 0.99% |
98,768
+2,012
| +2% | +$98.3K |
2013 Q2
8 quarters
|
|
21
Vanguard Total Bond Market
BND
$163B
| $4.51M | 0.95% |
55,464
+938
| +2% | +$77.1K |
2014 Q4
2 quarters
|
|
22
iShares MSCI Canada ETF
EWC
$7.28B
| $4.45M | 0.93% |
166,966
-30,514
| -15% | -$863K |
2013 Q2
8 quarters
|
|
23
WisdomTree Japan Hedged Equity Fund
DXJ
$2.35B
| $4.37M | 0.92% |
229,311
-17,571
| -7% | -$340K |
2013 Q2
8 quarters
|
|
24
State Street Energy Select Sector SPDR ETF
XLE
$42.8B
| $3.51M | 0.74% |
93,428
+2,516
| +3% | +$99.9K |
2013 Q2
8 quarters
|
|
25
iShares MSCI Emerging Markets ETF
EEM
$29.6B
| $2.61M | 0.55% |
65,937
-5,301
| -7% | -$222K |
2013 Q2
8 quarters
|
|
Similar funds
PRO
MBA
SIA
AP
MW
SBIA
LC
TW
Callan Capital's Q2 2015 Portfolio in Review
As of Q2 2015, Callan Capital held 73 positions worth $477M, up 1.4% from $470M the previous quarter. Its ten largest holdings account for 75% of the portfolio.
Callan Capital withdrew a net $17.8M in Q2 2015, closing 3 positions and reducing 20 holdings. Its most notable exit was Halozyme, an estimated $920K position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 97% of assets, down from 97% a quarter earlier, followed by Healthcare and Real Estate.
Against the trend, Callan Capital opened a new position in PIMCO Enhanced Short Maturity Active Exchange-Traded Fund worth $815K.
- Callan Capital's largest Q2 2015 buy was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund: 8,054 shares worth $815K.
- Callan Capital added most to Becton Dickinson in Q2 2015, an estimated $1.39M increase.
- Callan Capital's biggest Q2 2015 reduction was Vanguard FTSE Europe ETF, cutting an estimated $5.04M.
- Callan Capital fully exited Halozyme in Q2 2015, selling an estimated $920K.
- Callan Capital's ten largest holdings make up 75% of its $477M portfolio in Q2 2015.
- Callan Capital opened 5 new positions and closed 3 in Q2 2015.
- Callan Capital's portfolio value rose 1.4% quarter-over-quarter to $477M.
Based on Callan Capital's 13F filing for Q2 2015, filed 13 Aug 2015.